Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion

The Lancet

Volumn 341, Issue 8844, 1993, Pages 507-511

  Goldhaber, S Z ^a   Come, P C ^a   Lee, R T ^a   Braunwald, E ^a   Parker, J A ^b   Haire, W D ^c   Feldstein, M L ^d   Miller, M ^e   Toltzis, R ^f   Smith, J L ^g   Taveira de Silva, A M ^h   Mogtader, A ⁱ   McDonough, T J ^j  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^e DANBURY HOSPITAL   (United States)

^f CHRIST HOSPITAL   (United States)

^g GEISINGER MEDICAL CENTER   (United States)

^h GEORGETOWN UNIVERSITY HOSPITAL   (United States)

ⁱ ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^j EVANSTON HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; LUNG PERFUSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION;

ACUTE DISEASE; AGED; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; FEMALE; HEPARIN; HUMAN; LUNG; MALE; MIDDLE AGE; PULMONARY CIRCULATION; PULMONARY EMBOLISM; SUPPORT, NON-U.S. GOV'T; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VENTRICULAR FUNCTION, LEFT;

EID: 0027446870     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)90274-K     Document Type: Article

References (16)

1. Acute pulmonary embolism treated with tissue plasminogen activator
2. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator
3. Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning
4. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism
5. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomised controlled multicenter trial
6. The Urokinase Pulmonary Embolism Trial. A national cooperative study
7. A network algorithm for performing Fischer's exact test in r X c Contingency tables
8. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial
9. Value of the ventilation/perfusion scan in acute pulmonary embolism results of the Prospective Investigaton of Pulmonary Embolism Diagnosis (PIOPED)
10. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism: Plasminogen Activator Italian Multicenter Study 2
11. Intravenous and intrapulmonry recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism
12. Pulmonary embolism thrombolysis: a clarion call for international collaboration
13. Thrombolysis for pulmonary embolism